Autor según el artículo: Rey-Renones, Cristina; Martinez-Torres, Sara; Martin-Lujan, Francisco M; Pericas, Carles; Redondo, Ana; Vilaplana-Carnerero, Carles; Dominguez, Angela; Grau, Maria
Departamento: Medicina i Cirurgia; Ciències Mèdiques Bàsiques
Autor/es de la URV: Martín Lujan, Francisco Manuel
Palabras clave: Type-2 diabetes mellitus; Therapy; Risk-factors; People; Outcomes; New-york-city; Inhibitors; Glucose; Epidemiology; Covid-19; Bidirectional link; Antidiabetic treatment; Adults
Resumen: Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.
Áreas temáticas: Pharmacology & pharmacy; Medicine, research & experimental; Medicine (miscellaneous); General biochemistry,genetics and molecular biology; Ciencias sociales; Biochemistry, genetics and molecular biology (miscellaneous); Biochemistry, genetics and molecular biology (all); Biochemistry & molecular biology
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: paco.martin@urv.cat
Fecha de alta del registro: 2025-02-18
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://www.mdpi.com/2227-9059/10/9/2089
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Biomedicines. 10 (9): 2089-
Referencia de l'ítem segons les normes APA: Rey-Renones, Cristina; Martinez-Torres, Sara; Martin-Lujan, Francisco M; Pericas, Carles; Redondo, Ana; Vilaplana-Carnerero, Carles; Dominguez, Angela (2022). Type 2 Diabetes Mellitus and COVID-19: A Narrative Review. Biomedicines, 10(9), 2089-. DOI: 10.3390/biomedicines10092089
DOI del artículo: 10.3390/biomedicines10092089
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2022
Tipo de publicación: Journal Publications
Repositori URV